Cyana Therapeutics, LLC

CIK 2102097 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cyana Therapeutics, LLC.

Recent SEC filings

FiledFormAccession number
Dec 22, 2025D0002102097-25-000001